ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Me
Go back to ImmunityBio to Present New Comparative Data, Scientific Advances in Non-Muscle Invasive Bladder Cancer CIS and an Update on BCG Naïve Registrational Trial at American Urological Association Annual Me| (NASDAQ: IBRX) | Delayed: 7.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.22 | 52 Week High | $ | |||
| Open | $7.22 | 52 Week Low | $ | |||
| Day High | $7.22 | P/E | N/A | |||
| Day Low | $7.22 | EPS | $ | |||
| Volume | 54,008 | |||||
